Osteogenic scaffolds for bone reconstruction

BioResearch Open Access

Volumn 1, Issue 3, 2012, Pages 137-144

  Li, Ling jiang ^a   Liu, Ning ^a   Shi, Jian gang ^a   Liu, Qing ^b,c   Jia, Lian shun ^a   Yuan, Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b 3D Biotek LLC   (United States)

^c TONGJI UNIVERSITY   (China)

Author keywords

Bioabsorbable; Bone graft; Bone tissue engineering; Lamina reconstruction; Polycaprolactone; Scaffolds

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; POLYCAPROLACTONE; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABLE IMPLANT; BIOMECHANICS; BONE DEVELOPMENT; BONE GRAFT; BONE REMODELING; CONTROLLED STUDY; ILIAC BONE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; X RAY;

EID: 84891588575     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0226     Document Type: Article

References (35)

1. Mistry AS, Mikos AG. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol. 2005;94:1-22.
2. Hollister SJ, et al. Engineering craniofacial scaffolds. Orthod Craniofac Res. 2005;8:162-173.
3. Li J, et al. Fabrication of individual scaffolds based on a patient-specific alveolar bone defect model. J Biotechnol. 2010; 151:87-93.
4. Lin CY, Kikuchi N, Hollister SJ. A novel method for biomaterial scaffold internal architecture design to match bone elastic properties with desired porosity. J Biomech. 2004;37:623-636.
5. Hedberg EL, et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. J Biomed Mater Res A. 2005;72:343-353.
6. Holland TA, Tabata Y, Mikos AG. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release. 2003;91: 299-313.
7. Kretlow JD, Mikos AG. 2007 AIChE Alpha Chi Sigma Award: from material to tissue: biomaterial development, scaffold fabrication, and tissue engineering. AIChE J. 2008; 54:3048-3067.
8. Vehof JW, et al. Bone formation in transforming growth factor beta-1-coated porous poly(propylene fumarate) scaffolds. J Biomed Mater Res. 2002;60:241-251.
9. Young S, et al. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release. 2005;109: 256-274.
10. Habraken WJ, et al. In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A. 2009;91:614-622.
11. Ford LT. Complications of lumbar-disc surgery, prevention and treatment. Local complications. J Bone Joint Surg Am. 1968;50:418-428.
12. Fernand R, Lee CK. Postlaminectomy disc space infection. A review of the literature and a report of three cases. Clin Orthop Relat Res. 1986;209:215-218.
13. Shimazaki K, et al. Late recurrence of spinal stenosis and claudication after laminectomy due to an ossified extradural pseudocyst. Spine (Phila Pa 1976). 1991;16:221-224.
14. Shi J, et al. Clinical classification of cauda equina syndrome for proper treatment: a retrospective analysis of 39 patients. Acta Ortho. 2010;81:391-395.
15. Samy Abdou M, Hardy RJ. Epidural fibrosis and the failed back surgery syndrome: history and physical findings. Neurol Res. 1999;21 Suppl 1:S5-S8.
16. Ross JS, et al. Association between peridural scar and recurrent radicular pain after lumbar discectomy: magnetic resonance evaluation. ADCON-L European Study Group. Neurosurgery. 1996;38:855-861; discussion 861-863.
17. Ran B, et al. Novel biodegradable alpha-TCP/poly(amino acid) composite artificial lamina following spinal surgery for prevention of intraspinal scar adhesion. Eur Spine J. 2011;20:2240-2246.
18. Isaksson S, et al. Contribution of autogeneic membranous bone chips and bone paste to healing of rabbit skull defects. Scand J Dent Res. 1992;100:274-278.
19. Gie G, et al. Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg. 1993;75B: 14-21.
20. Nelissen R, et al. Revision hip arthroplasty with the use of cement and impaction grafting: histological analysis of four cases. J Bone Joint Surg. 1995;77A:412-422.
21. Schreurs B, et al. Acetabular reconstruction with impacted morsellised cancellous bone graft and cement: a 10- to l5-year follow-up of 60 revision arthroplasties. J Bone Joint Surg Am. 1998;80B:391-395.
22. Chiu JC, Stechison MT. Percutaneous vertebral augmentation and reconstruction with an intravertebral mesh and morcelized bone graft. Surg Technol Int. 2005;14:287-296.
23. Causa F, et al. Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response. J Biomed Mater Res A. 2006; 76:151-162.
24. Rohner D, et al. Individually CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone framework for experimental reconstruction of craniofacial defects in the pig. Mund Kiefer Gesichtschir. 2002;6:162-167.
25. Williams GM, Klein TJ, Sah RL. Cell density alters matrix accumulation in two distinct fractions and the mechanical integrity of alginate-chondrocyte constructs. Acta Biomater. 2005;1:625-633.
26. Ciapetti G, et al. Osteoblast growth and function in porous poly epsilon-caprolactone matrices for bone repair: a preliminary study. Biomaterials. 2003;24:3815-3824.
27. Williams JM, et al. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials. 2005;26:4817-4827.
28. Alvarez L, et al. Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease. Bone. 2001;29:447-452.
29. Burshell AL, et al. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. Bone. 2010;46:935-939.
30. Delmas PD. Biochemical markers of bone turnover in Paget's disease of bone. J Bone Miner Res. 1999;14 Suppl 2:66-69.
31. Kosowicz J, et al. Markers of bone formation and resorption in primary and secondary hyperparathyroidism. Pol Arch Med Wewn. 1998;99:287-297.
32. Minisola S, et al. Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int. 2002;13:171-175.
33. Okuno S, et al. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients. Osteoporos Int. 2005;16:501-519.
34. Saag KG, et al. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum. 2009;60:3346-3355.
35. Waller S, Ridout D, Rees L. Effect of haemodialysis onmarkers of bone turnover in children. PediatrNephrol. 2007;22:586-592.